Advancing Care in Myasthenia Gravis: What Can We Learn From the Multiple Sclerosis Community?

ENGAGE: Analyzing the value of virtual reality in a patient-centric immersive learning program in myasthenia gravis for healthcare professionals

Human in vitro neuromuscular junction model to functionally dissect the pathogenic mechanism of anti-AChR autoantibody-positive myasthenia gravis

Discovery of Zilucoplan: A Complement C5 Inhibitor for Treatment of Anti-Acetylcholine Receptor (AChR) Antibody-Positive Generalized Myasthenia Gravis (gMG)

Measuring the effect of rozanolixizumab using the Myasthenia Gravis Impairment Index: analyses from the randomized phase 3 MycarinG study

Final analysis from an open-label extension study of fenfluramine for the treatment of seizures in Lennox-Gastaut syndrome: long-term impact on patients and caregivers

Pyrimidine nucleos(t)ide therapy in patients with thymidine kinase 2 deficiency (TK2d): a multicenter retrospective chart review study

What Patients Don’t Say and Physicians Don’t Ask: A Needs Assessment in MG Integrating Patient and Healthcare Professional Perspectives

Improvement in Patient-Reported Symptoms of Generalised Myasthenia Gravis With Rozanolixizumab in the Randomised Phase 3 MycarinG Study Using the MG Symptoms PRO

Treatment patterns and disease burden of juvenile myasthenia gravis in the United States: a cohort study using healthcare claims databases (RWE0816)